- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Calcineurin Inhibitor Toxicity in Ireland
Total 37 results
-
Cancer Trials IrelandCompletedPain | Unspecified Adult Solid Tumor, Protocol Specific | Radiation Toxicity | Spinal Cord CompressionIreland
-
Children's Cancer and Leukaemia GroupUnknownCYP3A5 Gene as a Risk Factor for Kidney Damage in Young Patients With Cancer Treated With IfosfamideSarcoma | Unspecified Childhood Solid Tumor, Protocol Specific | Chemotherapeutic Agent ToxicityIreland, United Kingdom
-
Cancer Trials IrelandTerminatedEndometrial Cancer | Radiation Toxicity | Gastrointestinal Complications | Urinary ComplicationsIreland
-
National University of Ireland, Galway, IrelandClinical Research Facility Galway; CORRIB Research Centre for Advanced Imaging...RecruitingHeart Failure | Breast Cancer | Cardiomyopathies | Cardiotoxicity | Chemotherapeutic Toxicity | OncologyIreland
-
Pharvaris Netherlands B.V.Active, not recruitingHereditary Angioedema | Hereditary Angioedema Type I | Hereditary Angioedema Type II | Hereditary Angioedema Types I and II | Hereditary Angioedema Attack | Hereditary Angioedema With C1 Esterase Inhibitor Deficiency | Hereditary Angioedema - Type 1 | Hereditary Angioedema - Type 2 | C1 Esterase Inhibitor... and other conditionsUnited States, Poland, Germany, Austria, Bulgaria, Canada, Ireland, Italy, United Kingdom
-
St. James's Hospital, IrelandCompletedQuality of Life | Obesity | Physical Activity | Gastric Cancer | Esophageal Cancer | Sarcopenia | Surgery | Chemotherapeutic Toxicity | Oncology | Sarcopenic Obesity | Visceral Obesity | Complication of TreatmentIreland
-
St. James's Hospital, IrelandCompletedPneumonia | Adenocarcinoma | Respiratory Failure | Esophageal Cancer | Pulmonary Fibrosis | Surgery | Chemotherapy Effect | Radiation Toxicity | Squamous Cell Carcinoma | Radiation Pneumonitis | Radiation FibrosisIreland
-
MacroGenicsRecruitingProstate Cancer Recurrent | Immunotherapy | Androgen-Independent Prostatic Cancer | Androgen-Resistant Prostatic Cancer | Hormone Refractory Prostatic Cancer | Immune Checkpoint Inhibitor | Androgen-Independent Prostatic Neoplasms | Androgen-Insensitive Prostatic Cance | Inhibitory Checkpoint MoleculeUnited States, Spain, France, Belgium, United Kingdom, Poland, Georgia, Bulgaria, Puerto Rico, Australia
-
CSL BehringCompletedEmphysema | Alpha 1-proteinase Inhibitor DeficiencyAustralia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)CompletedLeukemia | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
German Breast GroupPfizer; AGO Study Group; Breast International Group; NSABP Foundation IncCompletedBreast Cancer | Hormonreceptor Positive | Her2-normal | Postneoadjuvant Treatment With CDK 4/6 Inhibitor | CPS-EG ScoreUnited States, Australia, Austria, Canada, France, Germany, Ireland, Japan, Korea, Republic of, Spain, United Kingdom
-
Royal Marsden NHS Foundation TrustUniversity College, London; The Leeds Teaching Hospitals NHS Trust; Belfast Health... and other collaboratorsUnknownProstate Cancer | Metastasis | Toxicity Due to Radiotherapy | Circulating Tumour DNAUnited Kingdom
-
Swedish Orphan BiovitrumCerner EnvizaCompletedHemophilia A With InhibitorFrance, Ireland, Italy, Norway, Germany, Kuwait, Saudi Arabia, Switzerland
-
ShirePPDCompletedAngiotensin Converting Enzyme Inhibitor Induced AngioedemaUnited States, Canada, United Kingdom, Israel
-
Novo Nordisk A/SCompletedCongenital Bleeding Disorder | Haemophilia A With Inhibitors | Haemophilia B With InhibitorsSlovakia, Spain, Argentina, Germany, Croatia, Italy, Canada, United Kingdom, Ireland, Sweden, France, United States, Czech Republic, Switzerland
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedCervical Cancer | Radiation ToxicityUnited States
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI); NRG OncologyCompletedLung Cancer | Radiation Toxicity | Oral Complications | Drug/Agent Toxicity by Tissue/OrganUnited States, Canada
-
ShireTerminatedACE Inhibitor Induced AngioedemaUnited States
-
Aalborg University HospitalRigshospitalet, Denmark; Copenhagen Trial Unit, Center for Clinical Intervention...CompletedHypoxemic Respiratory Failure | Oxygen ToxicityUnited Kingdom, Denmark, Finland, Iceland, Netherlands, Norway, Switzerland
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedColorectal Cancer | Neurotoxicity | Neuropathy | Chemotherapeutic Agent ToxicityUnited States, Puerto Rico
-
CSL BehringCompletedEmphysema | Alpha1-proteinase Inhibitor DeficiencyAustralia, Russian Federation, United States, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden, Canada, Czech Republic
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedColorectal Cancer | Anal Cancer | Drug/Agent Toxicity by Tissue/Organ | Radiation EnteritisUnited States
-
Novartis PharmaceuticalsCompletedTumor Pathway Activations Inhibited by DovitinibUnited States
-
Novo Nordisk A/SRecruitingHaemophilia A With Inhibitors | Haemophilia ATaiwan, Canada, Spain, Netherlands, Korea, Republic of, India, United States, United Kingdom, Portugal, Lithuania, Turkey, China, South Africa, Ireland, Italy, France, Japan, Belgium, Germany, Malaysia, Poland, Austria, Bulgaria, Denmark and more
-
Novo Nordisk A/SRecruitingHaemophilia A With Inhibitors | Haemophilia AUnited States, Korea, Republic of, France, Spain, Romania, Canada, Taiwan, China, Lithuania, Netherlands, India, South Africa, Russian Federation, Austria, Belgium, Czechia, Denmark, Germany, Ireland, Italy, Japan, Latvia, Malaysia, M... and more
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedMetastatic Cancer | Radiation Toxicity | Cognitive/Functional EffectsUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol Specific | Metastatic Cancer | Radiation ToxicityUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)TerminatedPain | Head and Neck Cancer | Mucositis | Radiation ToxicityUnited States, Canada
-
Radiation Therapy Oncology GroupNational Cancer Institute (NCI)CompletedHead and Neck Cancer | Radiation Toxicity | Oral ComplicationsUnited States, Canada
-
University of South FloridaNational Cancer Institute (NCI)CompletedBreast Cancer | Cardiac ToxicityUnited States
-
Southwest Oncology GroupNational Cancer Institute (NCI)CompletedBreast Cancer | Fatigue | Neurotoxicity | Neuropathy | Chemotherapeutic Agent ToxicityUnited States
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLymphoma | Cardiac ToxicityUnited States, Canada, Switzerland
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)Active, not recruitingLymphoma | Neurotoxicity | Therapy-related ToxicityUnited States, Canada
-
ImmunoGen, Inc.Not yet recruitingRecurrent Ovarian Cancer | Folate Receptor-Alpha PositiveUnited States, Spain, Australia, Belgium, Canada, France, Ireland, Italy
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedOvarian Clear Cell Cystadenocarcinoma | Ovarian Serous Cystadenocarcinoma | Fallopian Tube Carcinoma | Endometrial Adenocarcinoma | Primary Peritoneal Carcinoma | Malignant Ovarian Mixed Epithelial Tumor | Ovarian Brenner Tumor | Ovarian Mucinous Cystadenocarcinoma | Undifferentiated Ovarian Carcinoma | Gastrointestinal Complication and other conditionsUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Neuropathy | Stage IIIA Fallopian Tube Cancer | Stage IIIA Ovarian Cancer | Stage IIIA Primary Peritoneal Cancer | Stage IIIB Fallopian Tube Cancer | Stage IIIB Ovarian Cancer | Stage IIIB Primary Peritoneal Cancer | Stage IIIC Fallopian Tube Cancer | Stage IIIC Ovarian Cancer | Stage IIIC Primary... and other conditionsUnited States